Chameleon Biosciences
Winnie Wan is a board member at Chameleon Biosciences and a veteran in the biotech industry. Winnie has over 25 years of experience in developing and commercializing innovative technologies in the life sciences.
Ms. Wan has served as CEO and/or founder of several companies, including BEING BioPharma, Bell Biosystems, Inhalon Biopharma, Kryptos Biotechnologies, and OncoHealth Corp. Winnie was also a board director and advisor at Nanotech Biomachines, Inc., where they helped develop breakthrough biosystems for drug discovery. Prior to their work in the private sector, Ms. Wan was a faculty member at Santa Clara University.
Ms. Wan is a passionate advocate for the advancement of women in STEM fields. Winnie is a founding member of Life Science Angels, an angel investment group that funds early-stage life science companies, and they also serve on the board of directors for Chameleon Biosciences, Inc.
Winnie Wan has a PhD in Biochemistry from Yale University, a BA in Chemistry from Skidmore College, and an MBA in Business Management from Columbia Business School.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Chameleon Biosciences
Life Changing, Re-Dosable Gene Therapies: we are committed to longer, healthier lives for all, including kids and adults who can’t currently be treated. With EVADER™, our next generation, AAV based gene therapy platform technology we are addressing the...